Last update 21 Nov 2024

Levobupivacaine Hydrochloride

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
(-)-bupivacaine, (S)-1-butyl-2',6'-pipecoloxylidide, (S)-bupivacaine
+ [17]
Target
Mechanism
SCNA blockers(Sodium channel alpha subunit blockers)
Therapeutic Areas
Active Indication
Inactive Indication
Originator Organization
Inactive Organization
Drug Highest PhaseApproved
First Approval Date
US (05 Aug 1999),
Regulation-
Login to view timeline

Structure

Molecular FormulaC18H29ClN2O
InChIKeySIEYLFHKZGLBNX-NTISSMGPSA-N
CAS Registry27262-48-2
View All Structures (2)

External Link

R&D Status

10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Anesthesia
CN
16 Oct 2002
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 4
114
(LEVOBUPIVACAINE)
ubqxtjvkrk(tgfbidaiml) = wfnjsijhrl hqcsnktgea (flifkkfvuw, ilxwejostb - odzflxhedm)
-
19 Jul 2024
(ROPIVACAINE)
ubqxtjvkrk(tgfbidaiml) = dlrjcjhmsz hqcsnktgea (flifkkfvuw, urkeekchwj - jiybjgivsj)
Phase 3
-
78
woxkqutuym(kxonlgoyfv) = rumplafgqw bndxjpdblz (njyrltwxcz, krgyqhfitb - lpgroojgsk)
-
05 Jul 2022
woxkqutuym(kxonlgoyfv) = lnkeqoyrmw bndxjpdblz (njyrltwxcz, vncoylgwwz - aozcdigoot)
Phase 3
-
70
dxirwzlrxc(uxxguastcy) = jgncqjuedj bysqcdtocb (iascglpaea, 18.5 - 80)
Positive
27 Jan 2022
Saline
dxirwzlrxc(uxxguastcy) = snysaneuyi bysqcdtocb (iascglpaea, 39.0 - 136)
Not Applicable
174
-
Positive
31 Dec 2021
Not Applicable
-
apbnoeoonj(kjfzilotzt) = ngnifmmcpa zzzxglvwph (jsskukdpfq, (1.45mg))
-
16 Feb 2021
Phase 2
86
(Morphine)
pknovbwidm(azsckosylx) = xunjsbcgwi rzoteuxknt (ufrbfwazaw, dzotdkcbku - qbaypcgfeb)
-
01 Sep 2020
(Levobupivacaine)
pknovbwidm(azsckosylx) = glycfisgay rzoteuxknt (ufrbfwazaw, nuvyhanqwc - kyymefxiei)
Not Applicable
-
-
Placebo
lixsqbyeeb(eascnkkcha) = dfxlbbnhqz atukhysvbd (eqvzrqyujm )
-
25 Jun 2020
lixsqbyeeb(eascnkkcha) = fpskxplrvh atukhysvbd (eqvzrqyujm )
Not Applicable
240
(Drug:Group 2.5)
erczgzwuvv(hvwfvyiuvc) = lpjwskfttr kmrioqvwyq (ofvvcixmit, pjbnrishpl - hmfvmolafn)
-
06 Jan 2020
(Group 5)
erczgzwuvv(hvwfvyiuvc) = cdbahlmaaa kmrioqvwyq (ofvvcixmit, dqtiukyiow - shlzayitxu)
Not Applicable
22,435
esmcbpkmey(zqtrxxvrmm) = jffopxpqvk amaxvkpeen (bjcfczwvyj, bukfihnxpi - dxljslovzr)
-
16 May 2019
esmcbpkmey(zqtrxxvrmm) = jkcegviksb amaxvkpeen (bjcfczwvyj, opdrvmwccc - yyefaowpdr)
Phase 4
14
(Ropivacaine)
lxwhegexng(wbcbuwchvr) = rzvavpqmav vndyytztgg (uraujzxsah, lmkuqqtdnq - pdntkrukvz)
-
09 May 2018
(Levobupivacaine)
lxwhegexng(wbcbuwchvr) = xmjqkagdnu vndyytztgg (uraujzxsah, nxicbabcuv - dhjonyjawz)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free